Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Naratuximab Biosimilar – Anti-CD37, TSPAN26 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Naratuximab Biosimilar - Anti-CD37, TSPAN26 mAb - Research Grade |
|---|---|
| Source | CAS 1622327-39-2 |
| Species | Chimeric |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Naratuximab,K7153A,CD37, TSPAN26,anti-CD37, TSPAN26 |
| Reference | PX-TA1419 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Naratuximab Biosimilar - Anti-CD37, TSPAN26 mAb - Research Grade
General information on Anti-CD37/TSPAN26[Homo sapiens] (Naratuximab) Monoclonal Antibody
Naratuximab is investigated for the treatment of Relapsed or Refractory Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia.
Related products
Antigen
C-type lectin domain family 9 member A(CLEC9A)
PX-P4353 182€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.